CIK 0001094038
- Non-accelerated filer
- Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880277072
- Phone
- +1 713-400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 58 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-17 | Knobil Katharine Director | Grant or award · Stock Option (Right to Buy) | +84,411 | 84,411 | ||
| 2025-11-17 | Knobil Katharine Director | Grant or award · Stock Option (Right to Buy) | +137,330 | 137,330 | ||
| 2025-11-17 | Eansor Norman David Director | Grant or award · Stock Option (Right to Buy) | +84,411 | 84,411 | ||
| 2025-11-17 | Eansor Norman David Director | Grant or award · Stock Option (Right to Buy) | +137,330 | 137,330 | ||
| 2025-11-17 | ELMS STEVE Director | Grant or award · Stock Option (right to buy) | +84,411 | 84,411 | ||
| 2025-11-17 | ELMS STEVE Director | Grant or award · Stock Option (right to buy) | +137,330 | 137,330 | ||
| 2025-10-31 | Corzo Kathryn Penkus Director | Grant or award · Stock Option (Right to Buy) | +147,611 | 147,611 | ||
| 2025-10-31 | Vera Juan Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2025-02-12 | ELMS STEVE Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-02-12 | Knobil Katharine Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-02-12 | Eansor Norman David Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-02-12 | Vera Juan President and CEO | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-12-23 | ELMS STEVE Director | Purchase | +11,085 | $3.20 | $35K | 325,370 |
| 2024-12-23 | New Enterprise Associates 16, L.P. 10% owner | Purchase | +554,250 | $3.20 | $1.8M | 1,625,678 |
| 2023-06-06 | Eansor Norman David Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2023-06-06 | Knobil Katharine Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2023-06-06 | Wilson John Robert Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2023-06-06 | ELMS STEVE Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2023-05-10 | Vera Juan President and CEO | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-02-27 | Hoang Tsvetelina P VP, Research and Development | Grant or award · Employee Stock Option (right to buy) | +33,159 | 33,159 |
Page 1 of 6 · 119 trades